Horizon Therapeutics PLC
NASDAQ:HZNP
Horizon Therapeutics PLC
Cash from Investing Activities
Horizon Therapeutics PLC
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Horizon Therapeutics PLC
NASDAQ:HZNP
|
Cash from Investing Activities
-$142.9m
|
CAGR 3-Years
29%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
-70%
|
|
Alkermes Plc
NASDAQ:ALKS
|
Cash from Investing Activities
$53.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Cash from Investing Activities
-$25.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-236%
|
CAGR 10-Years
N/A
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Cash from Investing Activities
-$2.8m
|
CAGR 3-Years
-140%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-19%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Cash from Investing Activities
-$3.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Horizon Therapeutics PLC's Cash from Investing Activities?
Cash from Investing Activities
-142.9m
USD
Based on the financial report for Jun 30, 2023, Horizon Therapeutics PLC's Cash from Investing Activities amounts to -142.9m USD.
What is Horizon Therapeutics PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-70%
Over the last year, the Cash from Investing Activities growth was 38%. The average annual Cash from Investing Activities growth rates for Horizon Therapeutics PLC have been 29% over the past three years , -60% over the past five years , and -70% over the past ten years .